Stephan B. Dreyer

Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer

Christopher J. Halbrook, Corbin Pontious, Ilya Kovalenko et al. · Cell Metabolism · 2019 · 415 citations · Full text

Medicine, Oncology, Pharmacology +14

Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer

Stephan B. Dreyer, Rosanna Upstill‐Goddard, Viola Paulus-Hock et al. · Gastroenterology · 2020 · 173 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer

Holly Brunton, Giuseppina Caligiuri, Richard Cunningham et al. · Cell Reports · 2020 · 127 citations · Full text

Medicine, Cancer Biology, Oncology +17

Defining the molecular pathology of pancreatic body and tail adenocarcinoma

Stephan B. Dreyer, Nigel B. Jamieson, Rosanna Upstill‐Goddard et al. · British journal of surgery · 2018 · 125 citations · Full text

Medicine, Oncology, Pathology +15

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

Jessica L. Chitty, Michelle Yam, Lara Perryman et al. · Nature Cancer · 2023 · 124 citations · Full text

Medicine, Oncology, Pharmacology +13